Nightingale Health Oyj Class B
Total Valuation
USDAs of June 30, 2026, NIGHTINGALE HEALTH OYJ carries a market capitalization of 70.12M, placing it among publicly traded companies globally. Its enterprise value stands at 32.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 70.12M |
| Enterprise Value | 32.76M |
Important Dates
NIGHTINGALE HEALTH OYJ's next confirmed earnings release is scheduled for March 9, 2027.
| Earnings Date | 3/9/2027 |
Share Statistics
As of June 30, 2026, NIGHTINGALE HEALTH OYJ has 62.13M shares outstanding.
| Shares Outstanding | 62.13M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.46 |
Financial Position
As of June 30, 2026, NIGHTINGALE HEALTH OYJ maintains a current ratio of 6.37, meaning it holds 6.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.37 |
| Quick Ratio | 5.77 |
| Debt / Equity | 8.40 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 100.50 |
Balance Sheet
USDAs of June 30, 2026, NIGHTINGALE HEALTH OYJ holds 42.04M in cash and equivalents against 4.68M in total debt, resulting in a net debt position of -42.04M. Total book value stands at 55.68M, with working capital of 39.17M providing operational flexibility.
| Cash & Cash Equivalents | 42.04M |
| Total Debt | 4.68M |
| Net Debt | -42.04M |
| Equity (Book Value) | 55.68M |
| Book Value Per Share | 0.90 |
| Working Capital | 39.17M |